GLSI
Price:
$23.38
Market Cap:
$343.18M
Greenwich LifeSciences, Inc. functions as a clinical-stage biopharmaceutical company, dedicated to developing innovative cancer immunotherapies. These treatments are primarily focused on breast cancer and other HER2/neu-positive malignancies. Its flagship therapeutic candidate is GP2, an immunotherapy which has successfully completed its Phase IIb clinical trials. This drug is designed to prevent the recurrence of breast cancer in patients who have already undergone surgical removal of the tumor. Founded in 2006 and based in Stafford, Texas, the company was formerly known as Norwell, Inc. until it rebranded to Greenwich LifeSciences, Inc. in March 2018.
Industry
Biotechnology
IPO Date
2020-09-25
Stock Exchange
NASDAQ
Ticker
GLSI
According to Greenwich LifeSciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -814.48%. This represents a change of 219.56% compared to the average of -254.88% of the last 4 quarters.
The mean historical ROE of Greenwich LifeSciences, Inc. over the last ten years is -188.37%. The current -814.48% ROE has changed 332.38% with respect to the historical average. Over the past ten years (40 quarters), GLSI's ROE was at its highest in in the December 2019 quarter at 24.92%. The ROE was at its lowest in in the December 2025 quarter at -442.52%.
Average
-188.37%
Median
-17.03%
Minimum
-1081.25%
Maximum
253.65%
Discovering the peaks and valleys of Greenwich LifeSciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.42%
Maximum Annual ROE = 253.65%
Minimum Annual Increase = -102.66%
Minimum Annual ROE = -1081.25%
| Year | ROE | Change |
|---|---|---|
| 2025 | -1081.25% | 57.34% |
| 2024 | -687.21% | 417.85% |
| 2023 | -132.71% | 124.09% |
| 2022 | -59.22% | 247.65% |
| 2021 | -17.03% | 152.76% |
| 2020 | -6.74% | -102.66% |
| 2019 | 253.65% | 1.42% |
| 2018 | 16.70% | -9.48% |
The current ROE of Greenwich LifeSciences, Inc. (GLSI) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-633.72%
5-year avg
-395.48%
10-year avg
-188.37%
Greenwich LifeSciences, Inc.’s ROE is greater than Cognition Therapeutics, Inc. (-72.68%), greater than Atossa Therapeutics, Inc. (-84.91%), less than Tevogen Bio Holdings Inc. (241.39%), less than Oncolytics Biotech Inc. (5.21%), less than Surrozen, Inc. (309.79%), greater than TuHURA Biosciences, Inc. (-153.99%), greater than Seer, Inc. (-26.58%), less than Opus Genetics, Inc. (6.07%), greater than Agenus Inc. (-23.05%), greater than Immix Biopharma, Inc. (-73.23%),
| Company | ROE | Market cap |
|---|---|---|
| -72.68% | $106.69M | |
| -84.91% | $17.31M | |
| 241.39% | $39.91M | |
| 5.21% | $96.35M | |
| 309.79% | $173.85M | |
| -153.99% | $163.66M | |
| -26.58% | $95.67M | |
| 6.07% | $336.04M | |
| -23.05% | $124.93M | |
| -73.23% | $474.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Greenwich LifeSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Greenwich LifeSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Greenwich LifeSciences, Inc.'s ROE?
How is the ROE calculated for Greenwich LifeSciences, Inc. (GLSI)?
What is the highest ROE for Greenwich LifeSciences, Inc. (GLSI)?
What is the 3-year average ROE for Greenwich LifeSciences, Inc. (GLSI)?
What is the 5-year average ROE for Greenwich LifeSciences, Inc. (GLSI)?
How does the current ROE for Greenwich LifeSciences, Inc. (GLSI) compare to its historical average?